Communication Technologies: Bridging Gaps in Pharmaceutical Industry Connectivity
Nasir Ahmad Khan *
Department of Public Health First Moscow state medical university named after I.M Sechenov, Sechenov University Moscow, Russia.
Koshechkin Konstantin
Eurasian Academy of Good Practices, Head of Research Laboratory of Advanced Technologies, Russia.
*Author to whom correspondence should be addressed.
Abstract
In the highly regulated, intricate, and internationally integrated pharmaceutical sector, ensuring continuous connection across research, production, and distribution networks is a major difficulty. This article examines the ways in which communication technologies, such as telemedicine, medical information systems (MIS), artificial intelligence (AI), electronic health records (ERHs), and big data analytics, are transforming pharmaceutical operations. We look at the main issues with the pharmaceutical industry's connection, such as interoperability, regulatory barriers, and data security. We also highlight new developments that improve patient involvement, supply chain transparency, and real-time partnerships. In order to increase productivity, compliance, and creativity in the pharmaceutical industry, this study suggests using integrated communication frameworks and thoroughly examines recent developments, regional adoption patterns, and implementation challenges. This study indicates that while FHIR + AI has the potential to enhance efficiency and decrease data silos, scaling requires mandates and hybrid architectures.
Keywords: Pharmaceutical technologies, Electronic Health Records (EHRs), Medical Information Systems (MIS), Artificial Intelligence (AI), telemedicine, big data, FHIR, interoperability